Harvard Bioscience appoints Rob Gagnon and Seth Benson to its Board as Independent Directors, and names John Duke CEO
– USA, MA – Harvard Bioscience, Inc. (Nasdaq: HBIO) announced the appointments of Rob Gagnon and Seth Benson to its Board as Independent Directors, effective July 16, 2025, while current Board member John Duke will assume the role of President and CEO, succeeding Jim Green, who will retire effective July 28, 2025.…